The Europe Oncology Information Systems Market would witness market growth of 7.1% CAGR during the forecast period (2022-2028).
The data of cancer sufferer rehabilitation programs, treatment plans, treatment deliveries, treatment summaries, and diagnostic results are managed by the oncology information system (OIS). The OIS must be connected to other hospitals' information systems because it would enclose the exchange of information with other divisions within the healthcare industry. Information about the stage and treatment of cancer can help in the assessment and enhancement of therapy. OIS accredits better medical safety and work performance. A healthcare organization can keep cancer information by using a variety of tools, including paper-based (hospital registries), networks, etc.
In response to the increasing prevalence of oncology, it is anticipated that the industry for oncology information systems will grow. In addition to offering advantages over conventional data handling and validation techniques, it reduced manual labor while automating the process as well. Also, the oncology information system has broad application in healthcare settings for improving cancer patient care. As healthcare regulations evolved to support smart technology, the market for cancer information systems grew rapidly. Additionally, it enhances medical care for patients and aids in better managing those with cancer. These factors accounted for the rapid growth of the oncology information systems market.
The unchecked growth of abnormal cells in one or both lungs leads to lung cancer. Even though it can affect those who have never smoked, those who smoke have the highest risk of developing lung cancer. Lung cancer risk is influenced by a patient's smoking duration and quantity. Secondhand smoke, asbestos, some metals, some organic chemicals, radiation, air pollution, and diesel exhaust at work or in the environment are additional risk factors.
Better regulatory conditions are one of the main factors promoting national growth. The regulatory procedure has been streamlined by German regulatory authorities in recent years, making it simpler for business players to advertise their drugs in Germany. In addition, the availability of sophisticated gene therapy applications would be of great interest to medical professionals, contributing to the development oncology information system for the patients record.
The Germany market dominated the Europe Oncology Information Systems Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $225.6 Million by 2028. The UK market is anticipated to grow at a CAGR of 6.2% during (2022 - 2028). Additionally, The France market would showcase a CAGR of 7.9% during (2022 - 2028).
Based on Offering, the market is segmented into Solutions (Patient Information Systems and Treatment Planning Systems) and Professional Services. Based on Application, the market is segmented into Medical Oncology, Radiation Oncology, and Surgical Oncology. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Oncology Information Systems Market will Hit $3.4 Billion by 2028, at a CAGR of 7.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Oracle Corporation (Cerner Corporation), Koninklijke Philips N.V., Varian Medical Systems, Inc. (Siemens Healthineers), ViewRay, Inc., Accuray, Incorporated, Elekta AB, RaySearch Laboratories AB (Nasdaq, Inc.), Brainlab AG, DOSIsoft SA (Institut de cancérologie Gustave Roussy), and MIM Software Inc.
By Offering
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
